BBSRC Portfolio Analyser
Award details
ERASynBio2: An orthogonal, organism-independent expression platform based on extracytoplasmic function (ECF) sigma factors
Reference
BB/N006852/1
Principal Investigator / Supervisor
Professor Mark Buttner
Co-Investigators /
Co-Supervisors
Institution
John Innes Centre
Department
Molecular Microbiology
Funding type
Research
Value (£)
406,637
Status
Completed
Type
Research Grant
Start date
21/07/2015
End date
20/07/2018
Duration
36 months
Abstract
Orthogonality is a key feature of classical engineering approaches but a major challenge to Synthetic Biology (SynBio) due to the high degree of context dependence and interconnectivity in biological systems. ECFexpress will develop a SynBio design framework based on Extracytoplasmic Function sigma factors (ECFs) to implement highly orthogonal regulatory switches and circuits. ECFs represent ideal building blocks for SynBio applications, because they are modular, inherently orthogonal, universal, and scalable. Initially, we will evaluate the organism-independent potential of ECFs by implementing orthogonal ECF-based regulation in four phylogenetically highly diverse bacteria, including two biotechnological workhorses. This will allow extracting and establishing universal design rules for choosing and implementing orthogonal ECF-based natural switches in any bacterium. Subsequently, we will design and engineer novel synthetic ECF switches with increased orthogonality. This goal will be achieved by applying design strategies based on combinatorial synthesis and structure-guided mutational approaches. Finally, we will use rational forward design to build and evaluate complex synthetic circuits based on ECF switches. This combined theoretical and experimental evaluation of novel ECF-based circuits will allow us to benchmark their orthogonality and to explore the ECF circuit design space. ECFexpress strictly adheres to engineering principles by (i) applying defined standards in assembly, measurements and data management, (ii) establishing orthogonal parts and switches for biological circuit design, and (iii) developing a bioinformatics platform for data management, mathematical modelling and forward design. Taken together, ECFexpress aims at a foundational advance by implementing true orthogonality to bacterial cells. It will be directly applicable to projects in basic research and in the knowledge-based bio-economy.
Summary
Not required.
Impact Summary
Not required.
Committee
Research Committee A (Animal disease, health and welfare)
Research Topics
Microbiology, Synthetic Biology
Research Priority
X – Research Priority information not available
Research Initiative
Synthetic Biology ERA-NET (ERASynBio) [2014-2015]
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search